Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients

por Ponce-Bobadilla, Ana Victoria, Stodtmann, Sven, Eckert, Doerthe, Zhou, Wen, Liu, Wei, Mohamed, Mohamed-Eslam F.
Publicado 2022

A Population Pharmacokinetic Meta‐Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients

por Stodtmann, Sven, Nuthalapati, Silpa, Eckert, Doerthe, Kasichayanula, Sreeneeranj, Joshi, Rujuta, Bach, Bruce A., Mensing, Sven, Menon, Rajeev, Xiong, Hao
Publicado 2021

Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis

por Stodtmann, Sven, Nader, Ahmed, Polepally, Akshanth R., Suleiman, Ahmed A., Winzenborg, Insa, Noertersheuser, Peter, Ng, Juki, Mostafa, Nael M., Shebley, Mohamad
Publicado 2021

Effect of veliparib (ABT-888) on cardiac repolarization in patients with advanced solid tumors: a randomized, placebo-controlled crossover study

por Munasinghe, Wijith, Stodtmann, Sven, Tolcher, Anthony, Calvo, Emiliano, Gordon, Michael, Jalving, Mathilde, de Vos-Geelen, Judith, Medina, Diane, Bergau, Dennis, Nuthalapati, Silpa, Hoffman, David, Shepherd, Stacie, Xiong, Hao
Publicado 2016